Shaimaa K. Mostafa

557 total citations · 1 hit paper
6 papers, 376 citations indexed

About

Shaimaa K. Mostafa is a scholar working on Molecular Biology, Organic Chemistry and Biomaterials. According to data from OpenAlex, Shaimaa K. Mostafa has authored 6 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Biomaterials. Recurrent topics in Shaimaa K. Mostafa's work include Nanoparticle-Based Drug Delivery (2 papers), Synthesis and bioactivity of alkaloids (1 paper) and Synthesis and biological activity (1 paper). Shaimaa K. Mostafa is often cited by papers focused on Nanoparticle-Based Drug Delivery (2 papers), Synthesis and bioactivity of alkaloids (1 paper) and Synthesis and biological activity (1 paper). Shaimaa K. Mostafa collaborates with scholars based in Egypt and Saudi Arabia. Shaimaa K. Mostafa's co-authors include Samar Zuhair Alshawwa, Gihan S. Labib, Ragwa M. Farid, Abeer Ahmed Kassem, Salah A. Sheweita, Ahmed O. Elzoghby, Maha El Demellawy, Maged W. Helmy, Mona H. Ibrahim and Marwa F. Harras and has published in prestigious journals such as Applied Microbiology and Biotechnology, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Shaimaa K. Mostafa

5 papers receiving 369 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence

2022 252 citations Samar Zuhair Alshawwa, Abeer Ahmed Kassem et al. Pharmaceutics profile →

Peers

Countries citing papers authored by Shaimaa K. Mostafa

Since Specialization

Citations

This map shows the geographic impact of Shaimaa K. Mostafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaimaa K. Mostafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaimaa K. Mostafa more than expected).

Fields of papers citing papers by Shaimaa K. Mostafa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaimaa K. Mostafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaimaa K. Mostafa. The network helps show where Shaimaa K. Mostafa may publish in the future.

Co-authorship network of co-authors of Shaimaa K. Mostafa

This figure shows the co-authorship network connecting the top 25 collaborators of Shaimaa K. Mostafa. A scholar is included among the top collaborators of Shaimaa K. Mostafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaimaa K. Mostafa. Shaimaa K. Mostafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	A novel antibacterial approach: targeting methicillin-resistant Staphylococcus aureus with carvone nanoemulgel 2025 ·Applied Microbiology and Biotechnology ·Wafaa E. Soliman, Nancy S. Younis, Shaimaa K. Mostafa, Maged E. Mohamed, (unknown), Mounir M. Salem‐Bekhit, (unknown), Fakhria A. Al‐Joufi, (unknown)	0
2	Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation 2022 ·Bioorganic Chemistry ·Mona H. Ibrahim, Marwa F. Harras, Shaimaa K. Mostafa, (unknown), Omkulthom Al kamaly, Najla Altwaijry, Rehab Sabour	16
3	Preclinical studies on melanogenesis proteins using a resveratrol-nanoformula as a skin whitener 2022 ·International Journal of Biological Macromolecules ·Salah A. Sheweita, (unknown), Taha I. Zaghloul, Shaimaa K. Mostafa, Nazik A. Elgindy	3
4	Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence breakdown → 2022 ·Pharmaceutics ·Samar Zuhair Alshawwa, Abeer Ahmed Kassem, Ragwa M. Farid, Shaimaa K. Mostafa, Gihan S. Labib	252
5	Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy 2017 ·International Journal of Pharmaceutics ·Ahmed O. Elzoghby, Shaimaa K. Mostafa, Maged W. Helmy, Maha El Demellawy, Salah A. Sheweita	46
6	Multi-Reservoir Phospholipid Shell Encapsulating Protamine Nanocapsules for Co-Delivery of Letrozole and Celecoxib in Breast Cancer Therapy 2017 ·Pharmaceutical Research ·Ahmed O. Elzoghby, Shaimaa K. Mostafa, Maged W. Helmy, Maha El Demellawy, Salah A. Sheweita	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact